Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,089.74
(
-0.27%
)
US TECH 100
25,853.80
(
-0.07%
)
Dow Jones
49,339.89
(
-0.22%
)
Brent Oil
94.21
(
3.89%
)
Bitcoin
75,916.16
(
0.03%
)
News Focus
News Focus
Post# of 20607
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

GreeseMonkey

Send PM Follow Ignore
Followers 7
Posts 781
Boards Moderated 0
Alias Born 10/26/2021

GreeseMonkey

Re: jFrank1 post# 11739

Tuesday, 09/06/2022 1:48:28 PM

Tuesday, September 06, 2022 1:48:28 PM

Post# of 20607
The recent dilution wasn't used to fund trials, but to clean up remaining convertible debt. Cash flow from Tollovid sales and Provista Lab are funding operations and trials. Prior to shares issued in last 2 weeks to clean up debt, no shares were issued in previous 4 months.

Agree with you on EUA. That would be great news and I think we all know it's coming.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote